Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Prostate Carcinoma”

754 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 754 results

Early research (Phase 1)Looking for participantsNCT05176483
What this trial is testing

Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors

Who this might be right for
Renal Cell Carcinoma (RCC)Metastatic Castration-Resistant Prostate Cancer (mCRPC)Urothelial Carcinoma (UC)+7 more
Exelixis 1,314
Early research (Phase 1)Temporarily pausedNCT00664196
What this trial is testing

Trial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative Conditioning

Who this might be right for
Prostate Cancer
Roger Williams Medical Center 18
Not applicableTemporarily pausedNCT03236688
What this trial is testing

Detection of ARv7 in the Plasma of Men With Advanced Metastatic Castrate Resistant Prostate Cancer (MCRP)

Who this might be right for
Metastatic Castrate Resistant Prostate Cancer
Exosome Diagnostics, Inc. 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT02893917
What this trial is testing

Testing Two Oral Drugs Combination (Cediranib and Olaparib) Compared to a Single Drug (Olaparib) for Men With Advanced Prostate Cancer

Who this might be right for
Advanced Prostate Adenocarcinoma With Neuroendocrine DifferentiationCastration-Resistant Prostate CarcinomaMetastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation+3 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Active Not RecruitingNCT06463457
What this trial is testing

Comeback From Long coursE Androgen Deprivation Therapy (ADT) With RElugolix and Darolutamide (CLEARED)

Who this might be right for
Prostate CancerAdvanced Prostate CancerHormone Sensitive Prostate Cancer
Atish Choudhury, MD 33
Testing effectiveness (Phase 2)Looking for participantsNCT07410494
What this trial is testing

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
CancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more
Essen Biotech 85
Testing effectiveness (Phase 2)Looking for participantsNCT06568094
What this trial is testing

HRS-5041 Tablets Combined With Antitumor Therapy in Subjects With Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd. 100
Large-scale testing (Phase 3)Looking for participantsNCT06650579
What this trial is testing

REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac Trial

Who this might be right for
Recurrent Prostate CarcinomaStage III Prostate Cancer AJCC v8Stage IVA Prostate Cancer AJCC v8
Emory University 72
Not applicableApproved For MarketingNCT04100694
What this trial is testing

Early Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid Tumor

Who this might be right for
NRG1 FusionPancreatic CancerNon Small Cell Lung Cancer+8 more
Merus B.V.
Large-scale testing (Phase 3)Ended earlyNCT00705822
What this trial is testing

Combination of Docetaxel + Estramustine + Hydrocortisone Versus Docetaxel + Prednisone in Patients With Advanced Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Sanofi 54
Early research (Phase 1)Looking for participantsNCT07114601
What this trial is testing

LY4257496 in Participants With Cancer (OMNIRAY)

Who this might be right for
Breast NeoplasmsColorectal NeoplasmsProstate Neoplasm+4 more
Eli Lilly and Company 421
Early research (Phase 1)Study completedNCT00003439
What this trial is testing

Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)Ended earlyNCT02946996
What this trial is testing

Study of Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients Receiving Androgen Deprivation Therapy

Who this might be right for
Prostate Cancer
Medical University of South Carolina 41
Early research (Phase 1)Looking for participantsNCT05656573
What this trial is testing

CART-PSMA Cells for Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Nova Therapeutics LLC 20
Early research (Phase 1)Active Not RecruitingNCT06545942
What this trial is testing

Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorProstate Cancer+4 more
MOMA Therapeutics 220
Not applicableEnded earlyNCT03073473
What this trial is testing

Evaluation of the NantHealth GPS Cancer Test in Patients With Advanced Cancers

Who this might be right for
Pancreatic CancerMetastatic Breast CancerMetastatic Lung Cancer+3 more
Cota Inc. 40
Testing effectiveness (Phase 2)Study completedNCT00170157
What this trial is testing

Hormone Therapy and Ipilimumab in Treating Patients With Advanced Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaProstate CarcinomaRecurrent Prostate Carcinoma+2 more
Mayo Clinic 112
Testing effectiveness (Phase 2)Ended earlyNCT00126230
What this trial is testing

Trial of Docetaxel-Samarium in Patients With Hormone-Refractory Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Gustave Roussy, Cancer Campus, Grand Paris 55
Early research (Phase 1)Study completedNCT00313599
What this trial is testing

Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors

Who this might be right for
Bladder CancerBrain and Central Nervous System TumorsBreast Cancer+6 more
University of California, San Francisco 28
Not applicableLooking for participantsNCT02102477
What this trial is testing

Surgery Versus Radiotherapy for Locally Advanced Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Olof Akre 1,200
Load More Results
90